Le Lézard
Classified in: Science and technology
Subject: v

Topicus.com Coöperatief U.A. and Topicus.com Inc. declare a special dividend


TORONTO, March 05, 2024 (GLOBE NEWSWIRE) -- Topicus.com Inc. (the "Company") (TSXV: TOI), announced today the declaration by its subsidiary Topicus.com Coöperatief U.A. (the "Coop", and together with the Company "Topicus") of a special dividend in the amount of ?1.54 per ordinary unit (the "Coop Dividend"). As a result of its ownership in the Coop, the Company will receive approximately ?127.6 million of the aggregate amount of the Coop Dividend. As such, the Company has declared a ?1.54 per share special dividend payable on March 28, 2024, to all holders of its subordinate voting shares and super voting share of record as of the close of business on March 15, 2024 (the "Topicus Dividend"). The Topicus Dividend has been designated as an eligible dividend for the purposes of the Income Tax Act (Canada).

Robin van Poelje, the Chief Executive Officer of the Company, commented, "Topicus is pleased to distribute a one-time special dividend in the total amount of ?200 million to our shareholders. The board of Topicus has ensured sufficient liquidity to pursue our ongoing strategy of organic growth combined with strategic acquisitions."

About Topicus.com Inc.

The Company's subordinate voting shares are listed on the Toronto Venture Stock Exchange under the symbol "TOI". Topicus acquires, manages and builds vertical market software businesses.

For further information, contact:

Topicus.com Inc.
Jamal Baksh, Chief Financial Officer
Tel: (416) 861-9677
[email protected]
www.topicus.com



These press releases may also interest you

at 20:00
Affiliated Dermatologists (AD) is providing notice of a recent data security incident. At this time, AD is not aware of any misuse of any personal information in connection with this incident. What Happened? On March 5, 2024, AD detected it was the...

at 18:00
BetterLife Pharma Inc. ("BetterLife" or the "Company") , an emerging biotech company focused on the development and commercialization of non-hallucinogenic LSD-based therapeutics for mental disorders, today announced that the Company intends to...

at 17:45
Celonis, the global leader in Process Mining, today announced it has appointed Mark Jacobs to the role of Senior Vice President North America Sales. As the Go-to-Market leader for North America, Jacobs will work closely with new and existing...

at 17:05
DXC Technology , a leading Fortune 500 global technology services company, today announced it will participate in the following investor conferences: J.P. Morgan's Technology, Media, & Telecom 2024 Conference ? Raul Fernandez, President and CEO, is...

at 17:05
Intercontinental Exchange, Inc. ("ICE") announced today that it is commencing a private exchange offer (the "Exchange Offer") with respect to the outstanding 3.625% Senior Notes due 2028 (the "BK Notes") issued by Black Knight InfoServ, LLC, a...

at 17:00
Spyre Therapeutics, Inc. (the "Company" or "Spyre"), a development-stage biotechnology company advancing best-in-class antibody engineering, rational therapeutic combinations, and precision medicine approaches for the treatment of Inflammatory Bowel...



News published on and distributed by: